FINAL - October 20, 2021

PRESIDER/PRESENTER(s)

10:00 Welcome & Introductions Dr. Grace Lee (ACIP Chair)

Dr. Melinda Wharton (ACIP Executive Secretary, CDC)

10:30 Agency Updates

10:45 Pneumococcal Vaccines

Introduction

Considerations for age-based and risk-based use of PCV15/PCV20 among 

adults and proposed policy options

Discussion

Dr. Katherine Poehling (ACIP, WG Chair)

Dr. Miwako Kobayashi (CDC/NCIRD)

Dr. Miwako Kobayashi (CDC/NCIRD)

12:45 Break

1:15 Zoster Vaccines

Introduction

Work group interpretation of the EtR regarding use of RZV in 

immunocompromised adults, considerations for use, and proposed policy 

options 

Discussion

Dr. Camille Kotton (ACIP, WG Chair)

Dr. Tara Anderson (CDC/NCIRD)

Dr. Tara Anderson (CDC/NCIRD)

2:15 Break

2:30 Influenza Vaccines

Introduction

Phase II safety and immunogenicity study of the coadministration of 

Fluzone® High-Dose Quadrivalent Influenza Vaccine and a third dose of 

Change in Age Indication for Flucelvax Quadrivalent

Dr. Keipp Talbot (ACIP, WG Chair)

Dr. Ruvim Izikson (Sanofi Pasteur)

Dr. Lisa Grohskopf (CDC/NCIRD)

3:30 Break

3.45 Public Comment

4:15 Break

4:20 Votes

Pneumococcal Vote

Zoster Vote

5:00 Adjourn

10:15 Coronavirus Disease 2019 (COVID-19) Vaccines

Introduction

Moderna- Booster dose data

Janssen- Booster dose data 

National Instututues of Health, Mix and Match booster study

11:45 Break

12:00 Public comment

12:40 v-safe and VAERS - third dose and simultaneous vaccination 

COVID-19 Vaccine Safety Updates

Myocarditis- VAERS

Myocarditis- VSD

VaST Assessment

2:05 Break

2:20 COVID-19 vaccine effectiveness, primary series

Evidence to Recommendations

Clinical considerations

Policy Questions

Dr. Miwako Kobayashi (CDC/NCIRD)

Dr. Tara Anderson (CDC/NCIRD)

Dr. Grace Lee (ACIP Chair)

Dr. Melinda Wharton (ACIP Executive Secretary, CDC)

Dr. Matthew Daley (ACIP, WG Chair)

Dr. Jacqueline Miller (Moderna)

Dr. Penny Heaton & Dr. Macaya Douoguih (Janssen)

Dr. Robert Atmar (Baylor College of Medicine)

Dr. Anne Hause (CDC/NCEZID)

Dr. Tom Shimabukuro (CDC/NCEZID)

Dr. John Su (CDC/NCEZID)

Dr. Nicky Klein (KPNC)

Dr. Keipp Talbot (VaST Chair)

Dr. Jefferson Jones (CDC/NCIRD)

Dr. Kathleen Dooling (CDC/NCIRD)

Dr. Sujan Reddy (CDC/NCEZID)

Dr. Kathleen Dooling (CDC/NCIRD)

4:20 Break

Vote

5:00 Adjourn

Thursday, October 21, 2021

10:00 Welcome & Introductions

Wednesday, October 20, 2021

MEETING OF THE ADVISORY COMMITTEE ON IMMUNIZATION PRACTICES (ACIP)

Centers for Disease Control and Prevention

Atlanta, Georgia 30329 

October 20-21, 2021

page 1 of 2
FINAL - October 20, 2021

Acronyms

CDC

CMS Centers for Medicare and Medicaid Services 

COVID-19 Coronavirus disease 2019

EtR Evidence to Recommendations Framework

FDA Food and Drug Administration

GRADE

HRSA Health Resources and Services Administration

IHS Indian Health Service

NCHHSTP

NCIRD

NCEZID

NIAID

OIDP Office of Infectious Disease and HIV/AIDS Policy

RZV Recombinant Zoster Vaccine

SARS-CoV-2 Severe Acute Respiratory Syndrome Coronavirus 2

WG Work Group

WHO World Health Organization

VE Vaccine Effectiveness

National Center for Emerging and Zoonotic Diseases [of CDC/OID]

National Institute of Allergy and Infectious Diseases

Centers for Disease Control and Prevention

Grading of Recommendations Assessment, Development and Evaluation

National Center for HIV, Hepatitis, STD and TB Prevention [of CDC/OID] 

National Center for Immunization & Respiratory Diseases [of CDC/OID] 

page 2 of 2